1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer

Pfizer's list of patent-protected medicines is growing by leaps and bounds, but its stock price is under pressure.Pfizer (PFE 2.27%) investors have been through a lot of ups and downs over the past few years. If you've been on the sidelines, now could be a great time to buy the stock.Shares of Pfizer have been beaten severely in response to sinking sales of Comirnaty, its COVID-19 vaccine, and Paxlovid, an antiviral treatment. At its beaten-down price, it offers an eye-popping 5.9% dividend yield.Pfizer has ...